ArticleCancer research2021
Unraveling Ewing Sarcoma Tumorigenesis Originating from Patient-Derived Mesenchymal Stem Cells.
Open access · bronzeAbstract read
In one paragraph
Article in Cancer research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.
0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
46 citing papers in PubMed, 64 citations in OpenAlex.
- TENT5A Maintains MYC mRNA Stability to Enhance Osteosarcoma Stemness.Cancer research · 2026Article
- Does Longitudinal Targeted Panel Sequencing Provide Clinically Relevant Information in Translocation-Associated Sarcomas?JCO precision oncology · 2026Article
- Noncoding RNAs in Pediatric Solid Tumors: Advances in Understanding and Critical Knowledge Gaps.Cells · 2026Review
- Genetic and chromosomal dysregulations of progenitor cells in the etiology and pathogenesis of pediatric cancers.American journal of stem cells · 2026Review
- The hegemonic EWSR1::ETS oncoprotein overrules core regulatory circuitry principles in Ewing sarcoma.NPJ precision oncology · 2025Article
- One-Carbon Metabolism Inhibition Depletes Purines and Results in Profound and Prolonged Ewing Sarcoma Growth Suppression.Cancer research communications · 2025Article
- Targeting metastasis in paediatric bone sarcomas.Molecular cancer · 2025Review
- RNA-binding protein gene NOP58 exhibits crucial prognostic and therapeutic value in Ewing sarcoma.Hereditas · 2025Article
- Chromoplexy: A Pathway to Genomic Complexity and Cancer Development.International journal of molecular sciences · 2025Review
- Refined culture conditions with increased physiological relevance uncover oncogene-dependent metabolic signatures in Ewing sarcoma spheroids.Cell reports methods · 2025Article
- Emerging roles of cohesin-STAG2 in cancer.Oncogene · 2025Review
- Integrative analysis of Ewing's sarcoma reveals that the MIF-CD74 axis is a target for immunotherapy.Cell communication and signaling : CCS · 2025Article
- Chromoplexy.Methods in molecular biology (Clifton, N.J.) · 2025Article
- Review
- Modeling Extraordinary Response Through Targeting Secondary Alterations in Fusion-Associated Sarcoma.JCO precision oncology · 2024Article
- ATRX guards against aberrant differentiation in mesenchymal progenitor cells.Nucleic acids research · 2024Article
- Stemness and Cell Cycle Regulators and Their Modulation by Retinoic Acid in Ewing Sarcoma.Current issues in molecular biology · 2024Article
- Identification of Novel/RareInternational journal of molecular sciences · 2024Article
- Revolutionizing bone defect healing: the power of mesenchymal stem cells as seeds.Frontiers in bioengineering and biotechnology · 2024Review
- Advances and challenges in gene therapy strategies for pediatric cancer: a comprehensive update.Frontiers in molecular biosciences · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors at 5 institutions in 4 countries.
Anna SoleLaboratory of Genome Dynamics in the Immune System, Institut Imagine, INSERM UMR1163, Équipe Labellisée La Ligue Nationale Contre Le Cancer, Université Paris-Saclay, Université de Paris, Paris, France.
Sandrine GrossetêteINSERM U830, Équipe Labellisée La Ligue Nationale Contre Le Cancer, Paris Sciences et Lettres University, SIREDO Oncology Centre, Institut Curie, Paris, France.
Maxime HeintzéLaboratory of Genome Dynamics in the Immune System, Institut Imagine, INSERM UMR1163, Équipe Labellisée La Ligue Nationale Contre Le Cancer, Université Paris-Saclay, Université de Paris, Paris, France.
Loelia BabinLaboratory of Genome Dynamics in the Immune System, Institut Imagine, INSERM UMR1163, Équipe Labellisée La Ligue Nationale Contre Le Cancer, Université Paris-Saclay, Université de Paris, Paris, France.
Sakina ZaïdiINSERM U830, Équipe Labellisée La Ligue Nationale Contre Le Cancer, Paris Sciences et Lettres University, SIREDO Oncology Centre, Institut Curie, Paris, France.
Patrick RevyLaboratory of Genome Dynamics in the Immune System, Institut Imagine, INSERM UMR1163, Équipe Labellisée La Ligue Nationale Contre Le Cancer, Université Paris-Saclay, Université de Paris, Paris, France.ORCID 0000-0003-0758-8022
Benjamin RenoufMuseum National d'Histoire Naturelle, Inserm U1154, CNRS UMR 7196, Sorbonne Universités, Paris, France.
Anne De CianMuseum National d'Histoire Naturelle, Inserm U1154, CNRS UMR 7196, Sorbonne Universités, Paris, France.
Carine GiovannangeliMuseum National d'Histoire Naturelle, Inserm U1154, CNRS UMR 7196, Sorbonne Universités, Paris, France.
Cécile Pierre-EugèneINSERM U830, Équipe Labellisée La Ligue Nationale Contre Le Cancer, Paris Sciences et Lettres University, SIREDO Oncology Centre, Institut Curie, Paris, France.
Isabelle Janoueix-LeroseyINSERM U830, Équipe Labellisée La Ligue Nationale Contre Le Cancer, Paris Sciences et Lettres University, SIREDO Oncology Centre, Institut Curie, Paris, France.
Lucile CouronnéLaboratory of Onco-Hematology, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, Institut Imagine, INSERM UMR1163, University of Paris, Paris, France.ORCID 0000-0002-1357-5482
Sophie KaltenbachLaboratory of Onco-Hematology, Institut Necker - Enfants Malades, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France.
Mark TomishimaDevelopmental Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Maria JasinDevelopmental Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Thomas G P GrünewaldDivision of Translational Pediatric Sarcoma Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Olivier DelattreINSERM U830, Équipe Labellisée La Ligue Nationale Contre Le Cancer, Paris Sciences et Lettres University, SIREDO Oncology Centre, Institut Curie, Paris, France.
Didier Surdez *INSERM U830, Équipe Labellisée La Ligue Nationale Contre Le Cancer, Paris Sciences et Lettres University, SIREDO Oncology Centre, Institut Curie, Paris, France. erika.brunet@inserm.fr didier.surdez@balgrist.ch.ORCID 0000-0002-7118-7859
Erika Brunet *Laboratory of Genome Dynamics in the Immune System, Institut Imagine, INSERM UMR1163, Équipe Labellisée La Ligue Nationale Contre Le Cancer, Université Paris-Saclay, Université de Paris, Paris, France. erika.brunet@inserm.fr didier.surdez@balgrist.ch.ORCID 0000-0002-1726-4673
Inserm · FRCentre National de la Recherche Scientifique · FRHôpital Necker-Enfants Malades · FRMemorial Sloan Kettering Cancer Center · USGerman Cancer Research Center · DE
Funding
X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4MHomology-directed repair: BRCA2 and RAD51 paralogsR35CA253174 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Maria Jasin · 2020 to 2026
$6.7MNCI NIH HHS P30 CA008748NCI NIH HHS R35 CA253174
Abstract
Ewing sarcoma is characterized by pathognomonic translocations, most frequently fusing
Indexed as
Cell Transformation, NeoplasticDisease SusceptibilityAnimalsBiomarkersCells, CulturedComputational BiologyCRISPR-Cas SystemsDisease Models, AnimalGene EditingGene Expression ProfilingGene RearrangementGene TargetingHeterograftsHumansImmunophenotypingIn Situ Hybridization, FluorescenceBiomarkers
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.